Cargando…

Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study

BACKGROUND: The impact of the variant of concern (VOC) Alpha on the severity of COVID-19 has been debated. We report our analysis in France. METHODS: We conducted an exposed/unexposed cohort study with retrospective data collection, comparing patients infected by VOC Alpha to contemporaneous patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin-Blondel, Guillaume, Lescure, François-Xavier, Assoumou, Lambert, Charpentier, Charlotte, Chapplain, Jean-Marc, Perpoint, Thomas, Grouteau, Gaspard, Cordel, Hugues, Pialoux, Gilles, Pacanowski, Jérome, Thy, Michael, Bauvois, Adeline, Laureillard, Didier, Hamrouni, Fadia, Algarte-Genin, Michèle, Poissy, Julien, Descamps, Diane, Costagliola, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189443/
https://www.ncbi.nlm.nih.gov/pubmed/35698029
http://dx.doi.org/10.1186/s12879-022-07508-x
_version_ 1784725590014689280
author Martin-Blondel, Guillaume
Lescure, François-Xavier
Assoumou, Lambert
Charpentier, Charlotte
Chapplain, Jean-Marc
Perpoint, Thomas
Grouteau, Gaspard
Cordel, Hugues
Pialoux, Gilles
Pacanowski, Jérome
Thy, Michael
Bauvois, Adeline
Laureillard, Didier
Hamrouni, Fadia
Algarte-Genin, Michèle
Poissy, Julien
Descamps, Diane
Costagliola, Dominique
author_facet Martin-Blondel, Guillaume
Lescure, François-Xavier
Assoumou, Lambert
Charpentier, Charlotte
Chapplain, Jean-Marc
Perpoint, Thomas
Grouteau, Gaspard
Cordel, Hugues
Pialoux, Gilles
Pacanowski, Jérome
Thy, Michael
Bauvois, Adeline
Laureillard, Didier
Hamrouni, Fadia
Algarte-Genin, Michèle
Poissy, Julien
Descamps, Diane
Costagliola, Dominique
author_sort Martin-Blondel, Guillaume
collection PubMed
description BACKGROUND: The impact of the variant of concern (VOC) Alpha on the severity of COVID-19 has been debated. We report our analysis in France. METHODS: We conducted an exposed/unexposed cohort study with retrospective data collection, comparing patients infected by VOC Alpha to contemporaneous patients infected by historical lineages. Participants were matched on age (± 2.5 years), sex and region of hospitalization. The primary endpoint was the proportion of hospitalized participants with severe COVID-19, defined as a WHO-scale > 5 or by the need of a non-rebreather mask, occurring up to day 29 after admission. We used a logistic regression model stratified on each matched pair and accounting for factors known to be associated with the severity of the disease. RESULTS: We included 650 pairs of patients hospitalized between Jan 1, 2021, and Feb 28, 2021, in 47 hospitals. Median age was 70 years and 61.3% of participants were male. The proportion of participants with comorbidities was high in both groups (85.0% vs 90%, p = 0.004). Infection by VOC Alpha was associated with a higher odds of severe COVID-19 (41.7% vs 38.5%—aOR = 1.33 95% CI [1.03–1.72]). CONCLUSION: Infection by the VOC Alpha was associated with a higher odds of severe COVID-19. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07508-x.
format Online
Article
Text
id pubmed-9189443
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91894432022-06-14 Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study Martin-Blondel, Guillaume Lescure, François-Xavier Assoumou, Lambert Charpentier, Charlotte Chapplain, Jean-Marc Perpoint, Thomas Grouteau, Gaspard Cordel, Hugues Pialoux, Gilles Pacanowski, Jérome Thy, Michael Bauvois, Adeline Laureillard, Didier Hamrouni, Fadia Algarte-Genin, Michèle Poissy, Julien Descamps, Diane Costagliola, Dominique BMC Infect Dis Research BACKGROUND: The impact of the variant of concern (VOC) Alpha on the severity of COVID-19 has been debated. We report our analysis in France. METHODS: We conducted an exposed/unexposed cohort study with retrospective data collection, comparing patients infected by VOC Alpha to contemporaneous patients infected by historical lineages. Participants were matched on age (± 2.5 years), sex and region of hospitalization. The primary endpoint was the proportion of hospitalized participants with severe COVID-19, defined as a WHO-scale > 5 or by the need of a non-rebreather mask, occurring up to day 29 after admission. We used a logistic regression model stratified on each matched pair and accounting for factors known to be associated with the severity of the disease. RESULTS: We included 650 pairs of patients hospitalized between Jan 1, 2021, and Feb 28, 2021, in 47 hospitals. Median age was 70 years and 61.3% of participants were male. The proportion of participants with comorbidities was high in both groups (85.0% vs 90%, p = 0.004). Infection by VOC Alpha was associated with a higher odds of severe COVID-19 (41.7% vs 38.5%—aOR = 1.33 95% CI [1.03–1.72]). CONCLUSION: Infection by the VOC Alpha was associated with a higher odds of severe COVID-19. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07508-x. BioMed Central 2022-06-13 /pmc/articles/PMC9189443/ /pubmed/35698029 http://dx.doi.org/10.1186/s12879-022-07508-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Martin-Blondel, Guillaume
Lescure, François-Xavier
Assoumou, Lambert
Charpentier, Charlotte
Chapplain, Jean-Marc
Perpoint, Thomas
Grouteau, Gaspard
Cordel, Hugues
Pialoux, Gilles
Pacanowski, Jérome
Thy, Michael
Bauvois, Adeline
Laureillard, Didier
Hamrouni, Fadia
Algarte-Genin, Michèle
Poissy, Julien
Descamps, Diane
Costagliola, Dominique
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study
title Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study
title_full Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study
title_fullStr Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study
title_full_unstemmed Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study
title_short Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study
title_sort increased risk of severe covid-19 in hospitalized patients with sars-cov-2 alpha variant infection: a multicentre matched cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189443/
https://www.ncbi.nlm.nih.gov/pubmed/35698029
http://dx.doi.org/10.1186/s12879-022-07508-x
work_keys_str_mv AT martinblondelguillaume increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT lescurefrancoisxavier increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT assoumoulambert increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT charpentiercharlotte increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT chapplainjeanmarc increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT perpointthomas increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT grouteaugaspard increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT cordelhugues increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT pialouxgilles increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT pacanowskijerome increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT thymichael increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT bauvoisadeline increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT laureillarddidier increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT hamrounifadia increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT algartegeninmichele increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT poissyjulien increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT descampsdiane increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT costaglioladominique increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy
AT increasedriskofseverecovid19inhospitalizedpatientswithsarscov2alphavariantinfectionamulticentrematchedcohortstudy